reported that AHNAK mRNA levels were significantly downregulated in human breast cancer cell lines, particularly in triple-negative breast cancer cell lines, and that downregulation of AHNAK expression was associated with poor prognosis in TNBC. This evidence concerns the gene AHNAK and breast cancer.